The EPS projection of Monsanto Company (NYSE:MON) for quarter ended 2016-08-31 is $-0.02. A week before, the EPS forecast was $-0.02 against target of $-0.02, a month earlier. This estimate stood at $-0.02 60 days earlier versus forecast of $-0.02 90 days earlier, confirming a deviation of 0%.
Monsanto Company (NYSE:MON) reported that 18 days ago, the positive EPS revisions were 2 and negative revisions at 5.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Monsanto Company (NYSE:MON) in the preceding 120, 60, 30 and 90 days were 6, 0, 0 and 5, in that order.
As per the latest update, for the quarter closed 2, the EPS estimate of Monsanto Company (NYSE:MON) was $-0.02. This projection was computed after accounting 10 calls. As reported on 2016-04-06 the EPS was $2.42. The change was $-0.03, demonstrating a percentage deviation of -1.22%. The projections confirmed a standard deviation of 0.12.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Monsanto Company (NYSE:MON) stands at $2463.032 and the median estimate at $2459. Almost 4 analysts announced their estimates.
The highest estimate is $2592.63 while the lowest target is $2341.5 showing standard deviation of 102.953%.
As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of 1.348%.
A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. Monsanto Company (NYSE:MON) stated that the change in forecast was 3.39%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...